Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
 
 D DERMATOLOGICALS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
   J01 ANTIBACTERIALS FOR SYSTEMIC USE
   J02 ANTIMYCOTICS FOR SYSTEMIC USE
   J04 ANTIMYCOBACTERIALS
     J04A DRUGS FOR TREATMENT OF TUBERCULOSIS
       J04AA Aminosalicylic acid and derivatives
         J04AA01 4-Aminosalicylic acid [DG:DG00638]
           D00162  Aminosalicylic acid (USP)
           D00875  Aminosalicylate sodium (USP)
           D05460  Phenyl aminosalicylate (USAN)
         J04AA02 Sodium aminosalicylate
           D00875  Aminosalicylate sodium (USP)
         J04AA03 Calcium aminosalicylate
           D03368  Calcium para-aminosalicylate (JP19) <JP>
       J04AB Antibiotics
         J04AB01 Cycloserine
           D00877  Cycloserine (JP19/USP/INN) <JP/US>
         J04AB02 Rifampicin [DG:DG00639]
           D00211  Rifampin (USP) <JP/US>
           D08479  Rifampicin sodium
         J04AB03 Rifamycin [DG:DG00640]
           D02549  Rifamycin (USAN/INN)
           D08480  Rifamycin sodium (USAN)
         J04AB04 Rifabutin
           D00424  Rifabutin (JAN/USP/INN) <JP/US>
         J04AB05 Rifapentine
           D00879  Rifapentine (USAN/INN) <US>
         J04AB06 Enviomycin [DG:DG01219]
           D07897  Enviomycin (INN)
           D03278  Enviomycin sulfate (JP19)
         J04AB30 Capreomycin [DG:DG00641]
           D07607  Capreomycin (INN)
           D00135  Capreomycin sulfate (JAN/USP)
       J04AC Hydrazides
         J04AC01 Isoniazid [DG:DG00642]
           D00346  Isoniazid (JP19/USP/INN) <JP/US>
           D01501  Isoniazid calcium pyruvinate (JAN)
           D02002  Isoniazid sodium methanesulfonate hydrate (JAN)
           D09773  Isoniazid glucuronate sodium (JAN)
         J04AC02 Ftivazide
           D13017  Ftivazid (INN)
         J04AC51 Isoniazid, combinations
           D11578  Rifampin and isoniazid
       J04AD Thiocarbamide derivatives
         J04AD01 Protionamide
           D01195  Prothionamide (JP19)
         J04AD02 Tiocarlide
           D07246  Tiocarlide (INN)
         J04AD03 Ethionamide
           D00591  Ethionamide (JP19/USP/INN) <JP>
       J04AK Other drugs for treatment of tuberculosis
         J04AK01 Pyrazinamide
           D00144  Pyrazinamide (JP19/USP/INN) <JP/US>
         J04AK02 Ethambutol [DG:DG00643]
           D07925  Ethambutol (INN)
           D00878  Ethambutol hydrochloride (JP19/USP) <JP/US>
         J04AK03 Terizidone
           D07247  Terizidone (INN)
         J04AK04 Morinamide
           D07248  Morinamide (INN)
         J04AK05 Bedaquiline [DG:DG00644]
           D09872  Bedaquiline (USAN/INN)
           D09873  Bedaquiline fumarate (JAN/USAN) <JP/US>
         J04AK06 Delamanid
           D09785  Delamanid (JAN/USAN) <JP>
         J04AK07 Thioacetazone
           D08584  Thioacetazone (INN)
         J04AK08 Pretomanid
           D10722  Pretomanid (USAN/INN) <US>
       J04AM Combinations of drugs for treatment of tuberculosis
         J04AM01 Streptomycin and isoniazid
         J04AM02 Rifampicin and isoniazid
         J04AM03 Ethambutol and isoniazid
         J04AM04 Thioacetazone and isoniazid
         J04AM05 Rifampicin, pyrazinamide and isoniazid
           D10210  Rifampin, isoniazid and pyrazinamide
         J04AM06 Rifampicin, pyrazinamide, ethambutol and isoniazid
         J04AM07 Rifampicin, ethambutol and isoniazid
         J04AM08 Isoniazid, sulfamethoxazole and trimethoprim
         J04AM09 Pyrazinamide, ethambutol, isoniazid and lomefloxacin
         J04AM10 Pyrazinamide, ethambutol, protionamide and lomefloxacin
         J04AM11 Rifabutin, pyrazinamide and protionamide
         J04AM12 Rifampicin, pyrazinamide, isoniazid and levofloxacin
     J04B DRUGS FOR TREATMENT OF LEPRA
   J05 ANTIVIRALS FOR SYSTEMIC USE
   J06 IMMUNE SERA AND IMMUNOGLOBULINS
   J07 VACCINES
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: May 26, 2026
According to WHO's ATC 2026

» Japanese version